166 related articles for article (PubMed ID: 6238136)
1. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
Engstrom PF; Lavin PT; Moertel CG; Folsch E; Douglass HO
J Clin Oncol; 1984 Nov; 2(11):1255-9. PubMed ID: 6238136
[TBL] [Abstract][Full Text] [Related]
2. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.
Sun W; Lipsitz S; Catalano P; Mailliard JA; Haller DG;
J Clin Oncol; 2005 Aug; 23(22):4897-904. PubMed ID: 16051944
[TBL] [Abstract][Full Text] [Related]
3. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic treatment in patients with malignant carcinoid tumors. Response to streptozocin--alone or in combination with 5-FU.
Oberg K; Norheim I; Lundqvist G; Wide L
Acta Oncol; 1987; 26(6):429-32. PubMed ID: 2451530
[TBL] [Abstract][Full Text] [Related]
5. Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC-FFCD 9710.
Dahan L; Bonnetain F; Rougier P; Raoul JL; Gamelin E; Etienne PL; Cadiot G; Mitry E; Smith D; Cvitkovic F; Coudert B; Ricard F; Bedenne L; Seitz JF; ;
Endocr Relat Cancer; 2009 Dec; 16(4):1351-61. PubMed ID: 19726540
[TBL] [Abstract][Full Text] [Related]
6. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
[TBL] [Abstract][Full Text] [Related]
7. Metastatic carcinoid and islet cell tumours of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin.
Rougier P; Oliveira J; Ducreux M; Theodore C; Kac J; Droz JP
Eur J Cancer; 1991; 27(11):1380-2. PubMed ID: 1660291
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma.
Rivera E; Ajani JA
Am J Clin Oncol; 1998 Feb; 21(1):36-8. PubMed ID: 9499254
[TBL] [Abstract][Full Text] [Related]
9. Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma.
McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Heineman M; Hirsch J; Kelly WK; Scher HI; Bajorin DF
J Clin Oncol; 1997 Jun; 15(6):2449-55. PubMed ID: 9196161
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; Hanley JA
Cancer Clin Trials; 1979; 2(4):327-34. PubMed ID: 93982
[TBL] [Abstract][Full Text] [Related]
11. A single institution experience of streptozocin/fluorouracil combination chemotherapy: a case series.
Naidoo J; O'Toole D; Kennedy MJ; Reynolds JV; O'Connor M; O'Byrne K
Ir J Med Sci; 2012 Jun; 181(2):211-4. PubMed ID: 22048868
[TBL] [Abstract][Full Text] [Related]
12. Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours.
Dilz LM; Denecke T; Steffen IG; Prasad V; von Weikersthal LF; Pape UF; Wiedenmann B; Pavel M
Eur J Cancer; 2015 Jul; 51(10):1253-62. PubMed ID: 25935542
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group Study.
Bukowski RM; Johnson KG; Peterson RF; Stephens RL; Rivkin SE; Neilan B; Costanzi JH
Cancer; 1987 Dec; 60(12):2891-5. PubMed ID: 2960446
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy with 5-fluorouracil and streptozotocin in carcinoid tumors of gastrointestinal origin: experiences with 13 patients.
Ridolfi R; Amaducci L; Derni S; Fabbri L; Innocenti MP; Vignutelli P
J Chemother; 1991 Oct; 3(5):328-31. PubMed ID: 1839743
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of docetaxel in patients with metastatic carcinoid tumors.
Kulke MH; Kim H; Stuart K; Clark JW; Ryan DP; Vincitore M; Mayer RJ; Fuchs CS
Cancer Invest; 2004; 22(3):353-9. PubMed ID: 15493355
[TBL] [Abstract][Full Text] [Related]
16. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
Kim YH; Ajani JA; Carrasco CH; Dumas P; Richli W; Lawrence D; Chuang V; Wallace S
Cancer Invest; 1999; 17(7):474-8. PubMed ID: 10518191
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature.
Legha SS; Valdivieso M; Nelson RS; Benjamin RS; Bodey GP
Cancer Treat Rep; 1977 Dec; 61(9):1699-703. PubMed ID: 597818
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R
Am J Clin Oncol; 1988 Aug; 11(4):490-5. PubMed ID: 2841843
[TBL] [Abstract][Full Text] [Related]
19. Treatment of malignant carcinoid tumors: a randomized controlled study of streptozocin plus 5-FU and human leukocyte interferon.
Oberg K; Norheim I; Alm G
Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1475-9. PubMed ID: 2480243
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
